{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:06:10Z","timestamp":1790701570573,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ahjo.2026.100866","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:01:11Z","timestamp":1787389271000},"page":"100866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sex differences in single and combined cardiovascular medication use"],"prefix":"10.1016","volume":"70","author":[{"given":"T.C.X.","family":"Duk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Uijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.J.","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.E.","family":"Grobbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.E.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ahjo.2026.100866_bb0005","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","article-title":"European Society of Cardiology: cardiovascular disease statistics 2021","volume":"43","author":"Timmis","year":"2022","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100866_bb0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/CIRCRESAHA.117.311849","article-title":"Reducing the global burden of cardiovascular disease, part 2","volume":"121","author":"Leong","year":"2017","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100866_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057510","article-title":"Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study","volume":"12","author":"Rouette","year":"2022","journal-title":"BMJ Open"},{"issue":"23","key":"10.1016\/j.ahjo.2026.100866_bb0020","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1136\/heartjnl-2016-309402","article-title":"Sixteen-year nationwide trends in antithrombotic drug use in Denmark and its correlation with landmark studies","volume":"102","author":"Adelborg","year":"2016","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ahjo.2026.100866_bb0025","doi-asserted-by":"crossref","first-page":"e028205","DOI":"10.1161\/JAHA.122.028205","article-title":"US trends in cholesterol screening, lipid levels, and lipid-lowering medication use in US adults, 1999 to 2018","volume":"12","author":"Gao","year":"2023","journal-title":"J. Am. Heart Assoc."},{"issue":"9798","key":"10.1016\/j.ahjo.2026.100866_bb0030","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(11)61215-4","article-title":"Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE study): a prospective epidemiological survey","volume":"378","author":"Yusuf","year":"2011","journal-title":"Lancet"},{"issue":"41","key":"10.1016\/j.ahjo.2026.100866_bb0035","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1093\/eurheartj\/eht368","article-title":"Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998\u20132010","volume":"34","author":"Koopman","year":"2013","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100866_bb0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/ehjcvp\/pvw042","article-title":"Gender differences in the effects of cardiovascular drugs","volume":"3","author":"Tamargo","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"issue":"11","key":"10.1016\/j.ahjo.2026.100866_bb0045","doi-asserted-by":"crossref","first-page":"e014742","DOI":"10.1161\/JAHA.119.014742","article-title":"Sex differences in cardiovascular medication prescription in primary care: a systematic review and meta-analysis","volume":"9","author":"Zhao","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100866_bb0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.ahjo.2026.100866_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2018.05.002","article-title":"Polypharmacy, defined as taking five or more drugs, is inadequate in the cardiovascular setting","volume":"101","author":"Abolhassani","year":"2018","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ahjo.2026.100866_bb0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2147\/CLEP.S247575","article-title":"Existing data sources for clinical epidemiology: the PHARMO database network","volume":"12","author":"Kuiper","year":"2020","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ahjo.2026.100866_bb0065","series-title":"Pharmacoepidemiology [Internet]","first-page":"270","article-title":"Pharmacy-based medical record linkage systems","author":"Herings","year":"2012"},{"key":"10.1016\/j.ahjo.2026.100866_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S389598","article-title":"Completeness and representativeness of the PHARMO general practitioner (GP) data: a comparison with National Statistics","volume":"15","author":"Overbeek","year":"2023","journal-title":"Clin. Epidemiol."},{"issue":"25","key":"10.1016\/j.ahjo.2026.100866_bb0075","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"SCORE2 working group","year":"2021","journal-title":"Eur. Heart J."},{"issue":"25","key":"10.1016\/j.ahjo.2026.100866_bb0080","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/eurheartj\/ehab312","article-title":"SCORE2-OnP working group and ESC cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions","volume":"42","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ahjo.2026.100866_bb0085","author":"Nederlands Huisartsen Genootschap"},{"key":"10.1016\/j.ahjo.2026.100866_bb0090","author":"Nederlands Huisartsen Genootschap"},{"issue":"9","key":"10.1016\/j.ahjo.2026.100866_bb0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ahjo.2026.100866_bb0105","series-title":"R: A Language and Environment for Statistical Computing [Internet]","author":"R Core Team","year":"2021"},{"key":"10.1016\/j.ahjo.2026.100866_bb0110","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","first-page":"241","article-title":"Analysing data and undertaking meta-analyses","author":"Deeks","year":"2019"},{"issue":"5","key":"10.1016\/j.ahjo.2026.100866_bb0115","doi-asserted-by":"crossref","first-page":"e054584","DOI":"10.1136\/bmjopen-2021-054584","article-title":"Socioeconomic and health factors related to polypharmacy and medication management: analysis of a Household Health Survey in North West Coast England","volume":"12","author":"Downing","year":"2022","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.ahjo.2026.100866_bb0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s002280050445","article-title":"Polypharmacy: correlations with sex, age and drug regimen","volume":"54","author":"Bjerrum","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100866_bb0125","doi-asserted-by":"crossref","first-page":"e0264343","DOI":"10.1371\/journal.pone.0264343","article-title":"Fifteen-year trajectories of multimorbidity and polypharmacy in Dutch primary care\u2014a longitudinal analysis of age and sex patterns","volume":"17","author":"Vos","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ahjo.2026.100866_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.832994","article-title":"Prescription rates, polypharmacy and prescriber variability in Swiss general practice\u2014a cross-sectional database study","volume":"13","author":"Rachamin","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ahjo.2026.100866_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1189644","article-title":"Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011\u20132020)","volume":"14","author":"Cebrino","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ahjo.2026.100866_bb0140","author":"Auwerda"},{"key":"10.1016\/j.ahjo.2026.100866_bb0145","author":"Nederlands Huisartsen Genootschap"},{"key":"10.1016\/j.ahjo.2026.100866_bb0150","author":"Bartelink"},{"key":"10.1016\/j.ahjo.2026.100866_bb0155","author":"De Boer"},{"key":"10.1016\/j.ahjo.2026.100866_bb0160","author":"Dolmans"},{"issue":"7","key":"10.1016\/j.ahjo.2026.100866_bb0165","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/ehjcvp\/pvaf057","article-title":"Sex-related differences in cardiovascular pharmacotherapy: fiction or fact? Why can\u2019t we see the evidence?","volume":"11","author":"Tamargo","year":"2025","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"issue":"34","key":"10.1016\/j.ahjo.2026.100866_bb0170","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.ahjo.2026.100866_bb0175","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1139\/cjpp-2024-0040","article-title":"Sex-specific considerations in cardiovascular drug therapy","volume":"102","author":"Rabinovich-Nikitin","year":"2024","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100866_bb0180","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1152\/ajpregu.00864.2007","article-title":"Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition","volume":"294","author":"Sullivan","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ahjo.2026.100866_bb0185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2019.09.015","article-title":"Chronic medication intake in patients with stable coronary heart disease across Europe: evidence from the daily clinical practice. Results from the ESC EORP European survey of cardiovascular disease prevention and diabetes (EUROASPIRE IV) registry","volume":"300","author":"De Smedt","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"24","key":"10.1016\/j.ahjo.2026.100866_bb0190","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/heartjnl-2019-315134","article-title":"Sex disparities in the management of coronary heart disease in general practices in Australia","volume":"105","author":"Lee","year":"2019","journal-title":"Heart"}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226001552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226001552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:36:56Z","timestamp":1790699816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602226001552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S2666602226001552"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100866","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex differences in single and combined cardiovascular medication use","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100866"}}